Peroxisome proliferator activated nuclear receptors: Possible role in the development of atherosclerosis

被引：0
作者：
Evdokimova, MA [1 ]
Zateyshchikov, DA [1 ]
Sidorenko, BA [1 ]
机构：
[1] Presidential Med Ctr Russia, Moscow 121356, Russia
来源：
KARDIOLOGIYA | 2003年 / 43卷 / 11期
关键词：
peroxisome proliferator activated receptors; PPAR; atherosclerosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Peroxisome proliferator activated nuclear receptors (PPAR) belong to steroid receptors and are represented by 3 types: PPARalpha, PPARbeta, PPARgamma. PPARalpha is a key regulator of fatty acid P-oxidation, participates in development of inflammatory reaction and atherosclerosis formation. Main effects of fibrates are mediated through PPARalpha activation. PPARgamma plays important role in lipid metabolism, processes of cell differentiation and growth, participates in glucose utilization and mechanisms of insulin resistance. Specific activators of PPARgamma are glytazones - a group of antidiabetic drugs. The role of PPARbeta in atherosclerosis formation has not been elucidated yet however results of some studies indicate participation of this receptor in atherosclerosis. Data of studies devoted to the role of PPARs and polymorphic markers of these receptors in the process of atherosclerosis are reviewed.
引用
收藏
页码：41 / 48
页数：8
相关论文
共 45 条
[1]   PPARγ is required for placental, cardiac, and adipose tissue development [J].
Barak, Y ;
Nelson, MC ;
Ong, ES ;
Jones, YZ ;
Ruiz-Lozano, P ;
Chien, KR ;
Koder, A ;
Evans, RM .
MOLECULAR CELL, 1999, 4 (04) :585-595
[2]   Peroxisome proliferator-activated receptors in the cardiovascular system [J].
Bishop-Bailey, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (05) :823-833
[3]   Differential activation of adipogenesis by multiple PPAR isoforms [J].
Brun, RP ;
Tontonoz, P ;
Forman, BM ;
Ellis, R ;
Chen, J ;
Evans, RM ;
Spiegelman, BM .
GENES & DEVELOPMENT, 1996, 10 (08) :974-984
[4]   Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1 [J].
Delerive, P ;
De Bosscher, K ;
Besnard, S ;
Vanden Berghe, W ;
Peters, JM ;
Gonzalez, FJ ;
Fruchart, JC ;
Tedgui, A ;
Haegeman, G ;
Staels, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) :32048-32054
[5]   Reduction of atherosclerosis by the peroxisome proliferator-activated receptor α agonist fenofibrate in mice [J].
Duez, H ;
Chao, YS ;
Hernandez, M ;
Torpier, G ;
Poulain, P ;
Mundt, S ;
Mallat, Z ;
Teissier, E ;
Burton, CA ;
Tedgui, A ;
Fruchart, JC ;
Fiévet, C ;
Wright, SD ;
Staels, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) :48051-48057
[6]   Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits [J].
Duverger, N ;
Kruth, H ;
Emmanuel, F ;
Caillaud, JM ;
Viglietta, C ;
Castro, G ;
Tailleux, A ;
Fievet, C ;
Fruchart, JC ;
Houdebine, LM ;
Denefle, P .
CIRCULATION, 1996, 94 (04) :713-717
[7]   Peroxisome proliferator-activated receptor α gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease [J].
Flavell, DM ;
Jamshidi, Y ;
Hawe, E ;
Torra, LP ;
Taskinen, MR ;
Frick, MH ;
Nieminen, MS ;
Kesäniemi, YA ;
Pasternack, A ;
Staels, B ;
Miller, G ;
Humphries, SE ;
Talmud, PJ ;
Syvänne, M .
CIRCULATION, 2002, 105 (12) :1440-1445
[8]   Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta [J].
Forman, BM ;
Chen, J ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4312-4317
[9]   Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis [J].
Fruchart, JC ;
Duriez, P ;
Staels, B .
CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (03) :245-257
[10]   Platelet-derived growth factor promotes the expression of peroxisome proliferator-activated receptor γ in vascular smooth muscle cells by a phosphatidylinositol 3-kinase/Akt signaling pathway [J].
Fu, MG ;
Zhu, XJ ;
Wang, Q ;
Zhang, JF ;
Song, Q ;
Zheng, H ;
Ogawa, W ;
Du, B ;
Chen, YQE .
CIRCULATION RESEARCH, 2001, 89 (11) :1058-1064
12345